LOADING
Comparing Merck & Company (MRK) and Cisco Systems (CSCO) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | CSCO |
|---|---|---|
| Price | $151.31 | $110.80 |
| Change Today | -0.82% | -0.22% |
| Market Cap | $376.4B | $437.7B |
| P/E Ratio | 122.0 | 33.4 |
| Forward P/E | 55.6 | 20.7 |
| PEG Ratio | 10.47 | 1.02 |
| EPS | $1.25 | $3.33 |
| Revenue Growth (YoY) | 5.1% | 17.6% |
| Profit Margin | 4.8% | 20.9% |
| Return on Equity | 7.0% | 27.3% |
| Dividend Yield | 2.23% | 1.51% |
| Beta | 0.21 | 1.00 |
| 52-Week High | $154.49 | $129.88 |
| 52-Week Low | $75.81 | $64.79 |
| Volume | 136K | 182K |
Cisco Systems is the larger company by market capitalization. Cisco Systems trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Cisco Systems has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.